![](https://www.statnews.com/wp-content/uploads/2025/02/AdobeStock_78609576-1024x576.jpeg)
Opinion: U.S. taxpayers should stop funding clinical trials of industry-owned drugs
The National Cancer Institute (NCI) has had a taxpayer-funded drug development program for nearly 70 years, initiated at a time when there was no private investment in oncology drugs. I worked closely with NCI’s Investigational Drug Branch (IDB) from 1990 …